Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to King's College London
Filament has shipped PEX010 to King's College London for SLEEPY, a feasibility study of giving psilocybin just before sleep.Toronto, Ontario--(Newsfile Corp. - November 9, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and supplies...